30 Days of Parkinson’s: Living with Perspective and Hope
Apr 08, 2021 08:15 am | BNS Staff
 Day 8 of 30 This is Tamara Sutherland’s story: Our Parkinson’s story begins three and a half years after my husband, Marcus, and I were married, when he was 52. We thought his fatigue and mild clumsiness were due to working long hours as a landscaper and his inability to sleep. One day in August, […]
The post 30 Days of Parkinson’s: Living with Perspective and Hope appeared first on Parkinson's News Today. |
BlueRock Therapeutics has received permission from Health Canada to start a Phase 1 clinical trial evaluating DA01, an investigational cell therapy that aims to restore neurons lost to Parkinson’s disease. This clearance comes three months after the U.S. Food and Drug Administration (FDA) accepted the company’s request to launch the trial in the United States. […]
Aptinyx‘s Phase 2 clinical trial evaluating its investigational oral compound NYX-458 for the treatment of cognitive impairment and mild dementia associated with Parkinson’s disease is resuming patient screening after a temporary pause due to the COVID-19 pandemic. Recruitment is underway at multiple locations in the United States. More information and contacts is available here. “We are pleased […]
I miss the person I was as I dance around the person I am, and I try to figure out who I am becoming. Mine is an ambiguous loss. A loss that’s hard to understand with Parkinson’s disease. It is hard to be on this side of my life. I often feel like I am […]
I initially started this column by writing about my menopause journey and trying to add some levity to it. This was after my friends jokingly “welcomed me to the party.” However, as I continued writing and researching, I realized there may be more to the menopause story when it comes to the estimated 3 million […]
A neural map of the brain region central to Parkinson’s disease opens the possibility of new ways to treat this disorder and others that stem from damage to the nerve cells found there. The map, detailed in a recent study, might enable researchers to understand how specific nerve damage leads to disease symptoms by tracking […]
A new research project aims to determine whether medications developed to treat depression might be viable candidates for easing some troubling side effects of treatments for Parkinson’s disease, including levodopa. Parkinson’s is caused by the death or dysfunction of cells in the brain that make a neurotransmitter (brain signaling molecule) called dopamine. A standard treatment involves […]
Last weekend, I was exploring a South Carolinian swamp when my phone buzzed. It was my dad. “Call me after 2,” the text glowed on my phone. “OK,” I responded. After I’d wiped the swamp juice from my shoes and peeled back my muddy socks, I dialed my dad. Usually when he asks me to […]
